Deodialsingh Guiadeen

Statistics

Publications

Citations

234

H-Index

Active since

1998

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Johnson & Johnson (United States)

Deodialsingh Guiadeen is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, drug discovery, and organic chemistry.

Publications per year

1998–2008

Publications

The synthesis and SAR of rhodanines as novel class C β-lactamase inhibitors

Eugene B. Grant, Deodialsingh Guiadeen, Ellen Z. Baum et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 131 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

4-Amino-2-alkyl-butyramides as small molecule CCR2 antagonists with favorable pharmacokinetic properties

Gabor Butora, Gregori J. Morriello, Shankaran Kothandaraman et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 38 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Design, synthesis, and biological activity of diiminoisoindolines as complement component 3a antagonists

Eugene B. Grant, Deodialsingh Guiadeen, Monica Singer et al. · Bioorganic & Medicinal Chemistry Letters · 2001 · 20 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Ring-Expanded Nucleoside Analogues. 1,3-Dioxan-5-yl Pyrimidines

Gina Cadet, Ching‐See Chan, Rose Y. Daniel et al. · The Journal of Organic Chemistry · 1998 · 18 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

An expeditious synthesis of 3-(difluoromethoxy)- and 3-(trifluoromethoxy)-5,6,7,8-tetrahydro-1,6-naphthyridines

Deodialsingh Guiadeen, Shankaran Kothandaraman, Lihu Yang et al. · Tetrahedron Letters · 2008 · 14 citations

Natural Sciences, Chemistry, Medicinal Chemistry +4

1–5 of 6